In a clinical trial of 708 women, when capivasertib was combined with hormone therapy, it doubled the time before cancer progressed, from 3.6 months t...
Stay ahead of the news! Click ‘Yes, Thanks’ to receive breaking stories and exclusive updates directly to your device. Be the first to know what’s happening.